Meeting Report

Published in:
Volume 6 / Year 2017 / Issue 1

Biosimilar product labels in Europe: what information should they contain?

Page: 38-40

Abstract: In 2016, a multi-stakeholder workshop was held on the topic of ‘Biosimilar Labelling’. The discussions concerning labelling particulars are outlined in this meeting report. Submitted: 21 November 2016; Revised:… Read More »

Roundtable on biosimilars: pharmacovigilance, traceability, immunogenicity, 15 November 2016, Madrid, Spain

Author(s): , , , , , , , ,
Page: 31-7

Introduction: Biosimilars can offer a lower-cost alternative to current biological therapies and could help contribute to the much-needed savings for the healthcare systems. All biosimilars approved by the regulators must… Read More »

Go Back Print